Company Announcements

Change of Joint Corporate Broker

Source: RNS
RNS Number : 9173V
Braemar PLC
07 December 2023
 

7 December 2023

 

 

BRAEMAR PLC

("Braemar" or the "Company" or the "Group")

 

Change of Joint Corporate Broker

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering, and risk management advice to the shipping and energy markets, announces that, following the completion of the all share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Joint Corporate Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.

 

 

For further information, contact:

Braemar Plc



James Gundy, Group Chief Executive Officer

Tel +44 (0) 20 3142 4100

Grant Foley, Group Chief Financial Officer


Investec Bank plc


Gary Clarence / Harry Hargreaves / Alice King

Tel +44 (0) 20 7597 5970

Cavendish Capital Markets Limited

 

Ben Jeynes (Corporate Finance)

 

Leif Powis / Dale Bellis / Charlie Combe (Sales and ECM)

 

Tel +44 (0) 207 220 0500

Buchanan


Charles Ryland / Stephanie Whitmore /Jamie Hooper / Jack Devoy

Tel +44 (0) 20 7466 5000





 

Notes to Editors:

 

About Braemar Plc

Braemar provides expert investment, chartering, and risk management advice that enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping and energy. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

 

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

 

For more information, including our investor presentation, visit www.Braemar.com and follow Braemar on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPFSSFLMEDSEFE